MARCO CICARDI

ELENCO DEI LAVORI IN ESTENSO

1. A.Agostoni, B.Marasini, G.C.Martignoni, M.Cicardi: Hereditary angioneurotic oedema. Klin.Wschr. 53: 679-684, 1975. I.F. 0,9
2. B.Marasini, M.Cicardi, G.C.Martignoni and A.Agostoni: Treatment of hereditary angioedema. Klin.Wschr. 56: 819-23, 1978. I.F. 0,9
3. A.Agostoni, B.Marasini, M.Cicardi, G.C. Martignoni, L.Uziel, M.Pietrogrande: Hepatic function and fibrinolysis in patients with hereditary angioedema undergoing long-term treatment with tranexamic acid. Allergy 33: 216-21, 1978. I.F. 2,015
4. A.Agostoni, M.Cicardi, G.C.Martignoni, L.Bergamaschini and B.Marasini: Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. J.Allergy Clin.Immunol. 65: 72-79, 1980. I.F. 3,77
5. A.Agostoni, L.Bergamaschini, G.C.Martignoni, M.Cicardi and B.Marasini: Treatment of acute attacks of hereditary angioedema with C1 inhibitor concentrate. Ann.All. 44: 299-301, 1980. I.F. 1,0
6. L.Bergamaschini, M.Cicardi, A.Tucci, A.Agostoni: Effect of treatment with 17 alpha-alkylated androgens on C4 conversion products in hereditary angioedema studied by crossed immuno-electrophoresis. J.Clin.Pathol. 35: 728-31, 1982. I.F. 1,427
7. M.Cicardi, L.Bergamaschini, B.Marasini, G.Boccassini, A.Tucci, A.Agostoni: Hereditary angioedema: an appraisal of 104 cases. Am.J.Med.Sci. 284: 2-9, 1982. I.F.4,23
8. L.Bergamaschini, M.Cicardi, A.Tucci, M.Gardinali, D.Frangi, C.Valle and A.Agostoni: C1-INH concentrate in the therapy of hereditary angioedema. Allergy. 38: 81-84, 1983. I.F.2,015
9. A.Agostoni, M.Cicardi, L.Bergamaschini, M.Gardinali, D.Frangi, L.Gattinoni, A.Pesenti: Complement activation in ARDS patients treated with long-term extracorporeal CO2 removal. Trans.Am.Soc.Artif.Intern.Organs. 29: 227-29, 1983. I.F. 0,7
10. M.Quastel, R.Harrison, M.Cicardi, C.A.Alper and F.S. Rosen: Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and in patients with hereditary angioneurotic edema. J.Clin.Invest. 71: 1041-46, 1983. I.F. 9,66
11. M.Cicardi, L.Bergamaschini, A.Tucci, A.Agostoni, G.Tornaghi, G.Coggi, R.Colombi, G.Viale: Morphological evaluation of the liver in hereditary angioedema patients long-term treated with androgen-derivatives. J.Allergy Clin.Immunol. 72: 294-98, 1983. I.F.3,77
12. R.S.Geha, I.Quinti, K.F.Austen, M.Cicardi, A.Sheffer and F.S.Rosen: Acquired C1 inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. New Engl.J.Med. 312: 534-40, 1985.I.F. 27,76
13. M.Cicardi, D.Frangi, L.Bergamaschini, M.Gardinali, G.Sacchi, A.Agostoni: Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with echinococcus granulosus. Complement 2: 133.-39, 1985. I.F.1,4 –‘99
14. M.Gardinali, M.Cicardi, D.Frangi, L.Bergamaschini, M.Gallazzi, L.Gattinoni, A.Agostoni: Studies of complement activation in ARDS patients treated by long-term extracorporeal CO2 removal. Int.J.Artif.Organs 8: 135-40, 1985. I.F. 0,7
15. M.Gardinali, M.Cicardi, L.Bergamaschini, D.Frangi, M.Franzinelli, A.Anelli, D.Brancaccio and A.Agostoni: Comparison of different blood parameters for evaluation of complement activation during hemodialysis. Trans.Am.Soc.Artif.Intern.Organs. 31: 42-44, 1985.
16. J.Melamed, C.A.Alper, M.Cicardi and F.S.Rosen: The metabolism of C1 inhibitor and C1q in patients with acquired C1 inhibitor deficiency. J.Allergy Clin.Immunol. 77: 322-26,1986. I.F.3,77
17. A.E.Davis III, A.S.Whitehead, R.A.Harrison, A.Duphinais, G.A.P.Burns, M.Cicardi and F.S.Rosen: Human C1 inhibitor: characterization of cDNA clones and localization of the gene to chromosome 11. Proc.Natl.Acad.Sci.USA. 83: 3161-65, 1986. I.F. 9,04
18. M.Gardinali, M.Cicardi, D.Frangi, M.Franzinelli, F.Gattoni, C.Uslenghi and A.Agostoni: In vivo study of the complement system during infusion of radiographic contrast media. J.Allergy Clin.Immunol. 77: 690-92, 1986. I.F. 3,77
19. L.Bergamaschini, C.Valle, M.Franzinelli, M.Cicardi, A.Agostoni: Immunoreactive precipitation of C1 inhibitor protein from plasma of normal subjects and of patients with hereditary angioedema after isoelectric focusing. J.Clin.Chem.Clin.Biochem. 24: 719-722, 1986. I.F. 1,0
20. M.Cicardi, T.Igarashi, F.S.Rosen and A.E.Davis III: Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema. J.Clin.Invest. 79: 698-702, 1987. I.F. 9,66
21. M.Cicardi, T.Igarashi, M.S.Kim, D.Frangi, A.Agostoni and A.E.Davis III: Restriction fragment lenght polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema. J.Clin.Invest. 80: 1640-43, 1987. I.F. 9,66
22. M.Cugno, L.Bergamaschini, L.Uziel, M.Cicardi, A.Agostoni: Haemostasis contact system and fybrinolisis in hereditary angioedema (C1-inhibitor deficiency). J.Clin.Chem.Clin.Biochem. 26: 423-27, 1988. I.F. 1,0
23. T.Ariga, T.Igarashi, N.Ramesh, R.Parad, M.Cicardi and A.E. Davis III. Type I C1 inhibitor deficiency with small messenger RNA resulting from deletion of exon. J.Clin.Invest. 83: 1888-93, 1989. I.F. 9,66
24. N.J.Levy, N.Ramesh, M.Cicardi, R.A.Harrison and A.E.Davis III: Type II hereditary angioneurotic edema resulting from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene. Proc.Natl.Acad.Sci.USA. 87: 265-268, 1990. I.F. 9,04
25. P.Marino, M.Cugno, A.Preatoni, P.Cori, A.Rosti, L.Frontini, M.Cicardi: Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer. Br.J.Cancer 61: 434-5, 1990. I.F.2,93
26. M.Cugno, J.Nuijens, E.Hack, A.Eerenberg, D.Frangi, A.Agostoni and M.Cicardi. Plasma levels of C1 inhibitor complexes and cleaved C1 inhibitor in patients with hereditary angioneurotic edema. J.Clin.Invest. 85: 1215-20, 1990. I.F. 9,66
27. K.S.Aulak, M.Cicardi and R.A.Harrison. Identification of a new P1 residue mutation (444Arg-Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma. FEBS. 266: 13-16, 1990. I.F. 3,504
28. M.Cicardi, M.Gardinali, G.Bisiani, A.Rosti, P.Allavena and A.Agostoni. The systemic capillary leak syndrome: The appearance of interleukin-2-receptor-positive cells during attacks. Ann.Int.Med. 113: 475-477, 1990. I.F. 12,04
29. M.Benedetti, R.De Caterina, A.Bionda, M.Gardinali, M.Cicardi, S.Maffei, P.Gazzetti, P.Pistolesi, F.Vernazza, C.Michelassi, R.Giordani, L.Salvatore. Blood-artificial surface interactions, during cardiopulmonary bypass. A comparative study. Int. J. Artif. Organs. 13: 488-97, 1990. I.F. 0,7
30. M.Cicardi, L.Bergamaschini, M.Cugno, E.Hack, G.Agostoni, A.Agostoni. Long-term treatment of hereditary angioedema with attenuated androgens: a survey of 13 years experience. J.Allergy Clin. Immunol. 87: 768-773, 1991. I.F. 3,77
31. D.Frangi, M.Cicardi, A.Sica, F.Colotta, A.Agostoni, A.E.Davis III. Nonsense mutation affects C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. J.Clin.Invest. 88: 755-759, 1991. I.F. 9,66
32. A.Agostoni, M.Cicardi, W.Porreca. Peripheral edema due to increased vascular permeability: a clinical appraisal. Int. J. Clin. Lab. Res. 21: 241-46, 1992. I.F. 1,178
33. D.Frangi, K.S.Aulak, M.Cicardi, R.A.Harrison, A.E.Davis III. A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg 444-Leu) FEBS Letter 301: 34-36, 1992 I.F. 3,504
34. R.D'Amelio, A.Agostoni, R.Biselli, M.Brai, G.Caruso, M.Cicardi, A.Corvetta et al. Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroup in Italy. Scand. J. Immunol. 35: 589-595, 1992. I.F. 1,749
35. A.Agostoni, M.Cicardi, M.Gardinali, L.Bergamaschini. The complement system. Int. J. Immunopathol. Pharmacol. 5: 123-130, 1992. I.F.0,4
36. A.Agostoni, M.Cicardi. Hereditary and acquired C1 inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine. 71: 206-215, 1992. I.F. 4,48
37. Agostoni A, Cicardi M: Replacement therapy in hereditary and acquired angioedema. Pharmacol Res 1992; 26 Suppl 2: 148-9. I.F. 0,715 -1999
38. M.Cugno, C.E.Hack, J.P.de Boer, A.J.M.Eermberg, A.Agostoni, M.Cicardi. Plasmin generation during acute attacks in hereditary angioedema. J.Lab.Clin.Med. 121: 38-43, 1993. I.F. 1,808
39. M.Cicardi, G.Bisiani, M.Cugno, P.Sp„th, A.Agostoni. Autoimmune C1 inhibitor deficiency: Report of eight patients. Am.J.Med. 95: 169-175, 1993. I.F. 4,23
40. K.S.Aulak, E.Eldering, C.E.Hack, Y.P.T.Lubbers, R.A.Harrison, A.Mast, M.Cicardi, A.E.Davis III. A hinge region mutation in C1-inhibitor (Ala363 Thr) results in non substrate-like behaviour and in polymerization of the molecule. J.Biol.Chem. 268: 18088-18094, 1993. I.F. 6,963
41. M.Cugno, M.Cicardi, A.Agostoni. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for the prophylactic use of tranexamic acid. J.All.Clin.Immunol. 93: 870-76, 1994. I.F. 3,77
42. J.J.Bissler, M.Cicardi, V.H.Donaldson, P.A.Gatenby, F.S.Rosen, A.L.Sheffer, A.E.Davis III. A cluster of mutations within a short triplet repeat in the C1 inhibitor gene. Proc.Natl.Acad.Sci. 91: 9622-25, 1994. I.F. 9,04
43. A.Agostoni0, M.Gardinali, D.Frangi, C.Cafaro, L.Conciato, C.Sponzilli, A.Salvioni, M.Cugno, M.Cicardi. Activation of complement and kinin system after thrombolytic therapy in patients with acute myocardial infarction. Circulation 90: 2666-70, 1994. I.F. 9,76
44. M.Cicardi, P.M.Mannucci, R.Castelli, M.G.Rumi, A.Agostoni. Reduction in transmission of hepatitis C after introduction of a heat-treatment step in the production of C1-inhibitor concentrate. Transfusion 35: 209-212, 1995. I.F. 3,38
45. P.A.Testoni, M.Cicardi, L.Bergamaschini, S.Guzzoni, M.Cugno, M.Buizza, F.Bagnolo, A.Agostoni. Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy. Gastrointest. Endosc. 42, 301-305, 1995. I.F. 2,77
46. M.Cicardi, A.Agostoni. Hereditary angioedema. N.Engl.J.Med. 334: 1666-67, 1996 (Editorial). I.F. 27,76
47. M.Cugno, M.Cicardi, M.Colucci et al. Non neutralizing antibodies to tissue type plasminogen activator in serum of acute myocardial infarction patients treated with the recombinant protein. Thromb. Haemost. 76: 234-38, 1996. I.F. 4,58
48. M.Cugno, M.Cicardi, R.Coppola et al. Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology. 33: 361-64, 1996. I.F. 1,173
49. M.Cicardi, A.Beretta, M.Colombo et al. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angioedema. Clin.Exp.Immunol. 106: 475-79, 1996. I.F. 2,5
50. J.J.Bissler, K.S.Aulak, V.H.Donaldson, F.S.Rosen, M.Cicardi, R.A.Harrison, A.E.Davis. Molecular defects in hereditary angioneurotic edema. Proc.Ass.Am.Phys. 109; 164-73, 1997. I.F. 1,3
51. M.Cicardi, R.Castelli, L.C.Zingale et al. Side effects of long-term prophylaxis with attenuated-androgens in hereditary angioedema: comparison between treated and non-treated patients. J.Allergy Clin. Immunol. 99: 194-6, 1997. I.F.3,77
52. M.Cicardi, E.Berti, V.Caputo et al. Idiopathic capillary leak syndrome: evidence of CD8 positive lymphocytes surrounding damaged endothelial cells. J.Allergy Clin.Immunol. 99: 417-19, 1997. I.F. 3,77
53. M.Cugno, M.Cicardi, B.Bottasso et al. Activation of the coagulation cascade in C1 inhibitor deficiency. Blood 89: 3213-18, 1997. I.F. 9,5
54. M.Castelli, M.Cicardi, M.Gardinali, L.C.Zingale, C.Savi, M.Munari, A.Agostoni. Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency. Int. J. Artif. Organs. 20: 175-77, 1997. I.F. 0,7
55. F.De Filippi, R.Castelli, M.Cicardi, R.Soffredini, M.G.Rumi, E.Silini, P.M:Mannucci, M.Colombo. Transmission of hepatitis G virus in patints with angioedema treated with steam heated plasma concentrates of C1 inhibitor. Transfusion. 38: 307-11, 1998. I.F. 3,38
56. J.Nüssberger, M.Cugno, C.Amstruz, M.Cicardi, A.Pellacani, A.Agostoni. Plasma bradykinin in angioedema. Lancet. 351: 1693-97, 1998. I.F. 16,135
57. M.Cicardi, L.Bergamaschini, M.Cugno, A.Beretta, L.Zingale, M.Colombo, A.Agostoni. Pathogenetic and clinical aspects of C1-inhibitor deficiency. Immunobiol. 199: 366-76, 1998. I.F. 1,378
58. M.Cicardi, L.Bergamaschini, L.C.Zingale, D.Gioffrè, A.Agostoni. Idiopathic non histaminergic angioedema. Am. J. Med. 106: 650-54, 1999. I.F. 4,23
59. L.Bergamaschini, A.Miedico, M.Cicardi, R.Coppola, A.Agostoni. Consumption of C4-binding protein during complement activation. Clin. Exp. Immunol. 116: 220-24, 1999. I.F. 2,5
60. A.Agostoni, M.Cicardi, M.Cugno, L.C.Zingale, D.Gioffré, J.Nussberger. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology. 44, 21-25, 1999. I.F. 1,173
61. J.Nussberger Cugno, M. Cicardi, M. Agostoni, A. Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol. 104: 1321-1322, 1999. I.F. 3,77
62. M.Cicardi, B,Cesana, E.Del Ninno, E.Pappalardo, E.Silini, A.Agostoni, M.Colombo. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J.Viral Hepat. 7: 138-143, 2000. I.F. 2,157
63. F.Donatelli, G.Marchetto, M.Pocar, L.C.Zingale, M.Cicardi, A.Grossi. Does acquired angioedema increase the risk of surgery with cardiopulmonary bypass? J. Thorac. Cardiovasc. Surg. 120: 609-10, 2000. I.F. 3,057
64. E.Pappalardo, M.Cicardi, C.Duponchel, A.Carugati, S.Cloquet, A.Agostoni, M.Tosi. Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol. 106: 1147-54, 2000 I.F. 4,179
65. G.Lodi, A.Sardella, C.bez, F.Demarosi, M.Cicardi, A.Carrassi. Dental experience and self-perceived dental care needs of patients with angioedema. Spec. Care Dentist. 21: 27-31, 2001.
66. C.Duponchel, C.Di Rocco, M.Cicardi, M.Tosi. Rapid detection by fluorescence multiplex PCR of exon deletions and duplications in the C1 Inhibitor gene of hereditary angioedema patients. Hum Mut 17: 61-70, 2001. I.F. 6,134
67. A.Carugati, E.Pappalardo, L.C.Zingale, M.Cicardi. C1-inhibitor deficiency and angioedema. Mol immunol 38: 161-74, 2001 I.F. 1,973
68. Agostoni, A., and Cicardi, M. 2001. Drug-induced angioedema without urticaria. Drug Saf 24: 599 I.F. 3,327
69. Barilla-LaBarca, M. L., Gioffre, D., Zanichelli, A., Cicardi, M., and Atkinson, J. P. 2002. Acquired C1 esterase inhibitor deficiency in two patients presenting with a lupus-like syndrome and anticardiolipin antibodies. Arthritis Rheum 47: 223. I.F.7,379
70. E. Pappalardo, L.C.Zingale, A.Terlizzi, A. Zanichelli, A. Folcioni, M.Cicardi. Mechanisms of C1-inhibitor deficinecy. Immunobiol. 205, 542-51, 2002 I.F. 1,319
71. Massimo Cugno, Ju rg Nussberger, Marco Cicardi, Angelo Agostoni. Bradykinin and the pathophysiology of angioedema International Immunopharmacol. 3: 311– 317, 2003
72. E. Pappalardo, L.C. Zingale and M. Cicardi. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with danazol. Immunology Letters 86: 271-6, 2003 I.F. 1,710
73. M. Cicardi, L.C. Zingale, E. Pappalardo, A. Folcioni, A. Agostoni Angioedema due to acquired C1-inhibitor deficiency and risk of lymphoproliferative diseases. Medicine 82:274281, 2003 I.F. 4,500
74. Liliana Clemenza, Francesco Dieli, Marco Cicardi and Alfredo Salerno. Research on complement: old issues revisited and a novel sphere of influence. TRENDS in Immunology 24: 292-95, 2003. I.F.18,153
75. L.Bergamaschini, M.Cicardi. Recent advances in the use of C1 inhibitor as a therapeutic agent. Molecular Immunol. 40: 155-58, 2003. I.F.2,827
76. M.Cicardi, Lorenza C. Zingale, Luigi Bergamaschini, Angelo Agostoni.Angioedema associated with angiotensin converting enzyme inhibitors. Outcome after switching over a different treatment. Arch Int. Med.164:910-913, 2004. I.F. 7,508
77. Pappalardo E, Zingale LC, Cicardi M. C1 inhibitor gene expression in patients with hereditary angioedema: Quantitative evaluation by means of real-time RT-PCR. J Allergy Clin Immunol 2004; 114:638-44. I.F. 7,205
78.  Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L, et al. Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 2004; 114:629-37. I.F. 7,205
79. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo A, Cicardi M et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-S131 I.F.7,205
80. Cicardi M, Bissler JJ, Sullivan KE. Swelling isn't swell. Clin Immunol 2004; 113:231-3. I.F. 3,034
81. Cicardi M, Zingale L, Zanichelli A, Pappalardo E, Cicardi B. C1 inhibitor: molecular and clinical aspects. Springer Semin Immunopathol 2005; 27:286-98. I.F. 3,08
82. Beltrami L, Zingale LC, Carugo S, Cicardi M. Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it. Expert Opin Drug Saf 2006; 5:643-9. I.F. 3,26
83. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, et al. Angioedema without urticaria: a large clinical survey. Cmaj 2006; 175:1065-70. I.F. 7,04
84. Zingale LC, Castelli R, Zanichelli A, Cicardi M. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006; 26:669-90. I.F. 1,835

LETTERE ALL'EDITORE SU RIVISTE RECENSITE DAL

CURRENT CONTENTS LIFE SCIENCE

1. A.Agostoni, B.Marasini, M.Cicardi, G.C.Martignoni: Intermittent therapy with danazol in hereditary angioedema. Lancet i: 453, 1978.

1. A.Agostoni, M.Cicardi, B.Marasini, G.C.Martignoni: OedŠme angio-neurotique hŠrŠditaire: traitement des crises aigues. Nouv.Press Med. 8: 704, 1979.

1. A.Agostoni, M.Cicardi, L.Bergamaschini, G.Boccassini, A.Tucci: C1-inhibitor for treatment of hereditary angioedema. New Engl.J.Med. 203: 526, 1980.

1. A.Agostoni, M.Cicardi. Contraindications to the use of angioetensin converting enzyme inhibitors in patients deficient in C1 esterase inhibitor. Am. J. Med. 90: 278, 1991.

1. M.Gardinali, M.Cicardi, A.Agostoni. Invest. Radiol. 26: 918, 1991.

1. F. Pecchin, Agostoni A., Bertoli G., Cicardi M., Ghiringhelli P. Vasculitis involving lung, toes, and kidneys in a patient with angioedema: a common pathogenesis. Clin. Nephr. 40: 120-21, 1993.

1. M.Cicardi, M.Cugno, A.Agostoni. Cardioprotective effect of C1-inhibitor. Circulation. 92: 2758-59, 1995.

1. Beretta, A.Zanichelli, A.Agostoni, M.Cicardi, A.Gringeri. C1 inhibitor function and anti C1 inhibitor autoantibodies in patients with HIV type I infection. AIDS Res. Hum. Retrovirouses (letter) 15: 95, 1999.

1. Cicardi M, Agostoni A, Davis AE: Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000; 133(10): 837-8.

1. Nussberger J, Cugno M, Cicardi M. Bradykinin mediated angioedema. N Engl, J, Med. 374: 621-22, 2002 (letter) 

CAPITOLI DI LIBRI

1. L.Bergamaschini, G.Boccassini, M.Cicardi: Immunobiochimica del complemento. I Quaderni di Biochimica. Ed. Piccin, Padova. 21: 1-30, 1981.

1. M.Cicardi, D.Frangi: Genetic and acquired C1-inhibitor deficiency. Complement and Immunological Diseases Ed. M.D.Kazatchkine in BailliŠre's Clinical Immunology and Allergy. 2: 405-16, 1988.

1. A.Agostoni, M.Cicardi, M.Gardinali: Systemic capillary leak syndrome. in Advances in Vascular Pathology. A.Strano, S.Novo Eds. Elsevier Science Publishers. pg 181-186, 1990.

1. A.Agostoni, M.Cicardi, M.Cugno, E.Storti. Clinical problems in the C1 inhibitor deficient patient. Behring Inst. Mitt. 93, 306-312, 1993

1. A.E.Davis, J.Bissler, M.Cicardi. Mutations in the C1 inhibitor gene that result in angioneurotic edema. Behring Inst. Mitt. 93, 313-320, 1993

1. A.E.Davis III, M.Cicardi. C1 inhibitor autoantibodies. Autoantibodies J.B.Peter and Y.Shoenfeld pp. 126-131, 1996.

1. A.Agostoni, M.Cicardi. Autoimmunità nell’angioedema. In Le malattie autoimmuni, C.Betterle Piccin pp. 633-40. 2001.